Substituted Aromatic Sulfur Compounds and Methods of Their Use
申请人:Cephalon, Inc.
公开号:US20140005175A1
公开(公告)日:2014-01-02
Compounds of formula II are described:
wherein D, n, R
a
, R
b
, and R
c
are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula II for treating or reducing the risk of peritoneal carcinomatosis in a patient.
[EN] VINYL -ARYL - SULFONES FOR USE IN PERITONEAL CARCINOMATOSIS<br/>[FR] COMPOSÉS SOUFRÉS AROMATIQUES SUBSTITUÉS ET PROCÉDÉS DE LEUR UTILISATION
申请人:CEPHALON INC
公开号:WO2012116151A3
公开(公告)日:2013-01-03
US9475766B2
申请人:——
公开号:US9475766B2
公开(公告)日:2016-10-25
[EN] SUBSTITUTED AROMATIC SULFUR COMPOUNDS AND METHODS OF THEIR USE<br/>[FR] COMPOSÉS SOUFRÉS AROMATIQUES SUBSTITUÉS ET PROCÉDÉS DE LEUR UTILISATION
申请人:CEPHALON INC
公开号:WO2012116151A2
公开(公告)日:2012-08-30
Compounds of formula II are described, wherein D, n, Ra, Rb, and Rc are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula II for treating or reducing the risk of peritoneal carcinomatosis in a patient.
Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread
作者:Yi Shen、Craig A. Zificsak、Jill E. Shea、Xuegang Lao、Oana Bollt、Xiufen Li、Joseph G. Lisko、Jay P. Theroff、Courtney L. Scaife、Mark A. Ator、Bruce A. Ruggeri、Bruce D. Dorsey、Scott K. Kuwada
DOI:10.1021/jm501437v
日期:2015.2.12
The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2E)-3-[(4-tert-butylphenyl)sulfonyl]acrylonitrile (1) induced cancer cell apoptosis during adhesion to normal mesothelial cells which line the peritoneum. We recently demonstrated that the sulfonylacrylonitrile portion of 1 and hydrophobic aryl substitution were essential for pro-apoptotic activity in cancer cells. Here we synthesized a diverse series of analogues of 1 in order to improve the efficacy and pharmaceutical properties. Analogues and 1 were compared in their ability to cause cancer cell death during adhesion to normal mesothelial cell monolayers. Potent analogues identified in the in vitro assay were validated and found to exhibit improved inhibition of intra-abdominal cancer in two clinically relevant murine models of ovarian and pancreatic cancer spread and metastasis, highlighting their potential clinical use as an adjunct to surgical resection of cancers.